In osteosarcoma, nuclear CaMKIIα phosphorylates Tiam1 to activate Rac1, thereby reducing p21CIP1, increasing Rb phosphorylation, and promoting G1/S progression; knockdown of CaMKIIα reverses these effects [49]. The gene discussed is CAMK2A; the disease is osteosarcoma.